NASDAQ:GMAB - Genmab A/S News Headlines

$20.11

-0.29 (-1.42 %)

(As of 08/23/2019 04:00 PM ET)

Add

Today's Range

$20.04

Now: $20.11▼

$20.40

50-Day Range N/A

52-Week Range

$12.10

Now: $20.11▼

$21.45

Volume160,331 shs

Average Volume468,716 shs

Market Capitalization$2.59 billion

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Source:

Date	Headline
	$0.18 Earnings Per Share Expected for Genmab A/S (NASDAQ:GMAB) This Quarter www.americanbankingnews.com - August 24 at 2:18 AM
	Genmab Announces Preliminary Data to be Presented at IASLC 2019 World Conference on Lung Cancer finance.yahoo.com - August 22 at 12:01 PM
	Genmab A/S's (NASDAQ:GMAB) Quiet Period To End on August 27th www.americanbankingnews.com - August 20 at 1:20 AM
	Genmab A/S: Daratumumab Abstracts Selected for Presentation at 17th International Myeloma Workshop www.bloomberg.com - August 19 at 3:16 PM
	Genmab A/S: Genmab Announces Financial Results for the First Half of 2019 and Updates 2019 Financial Guidance www.bloomberg.com - August 14 at 3:15 PM
	What Should Investors Know About The Future Of Genmab A/S's (CPH:GMAB)? finance.yahoo.com - August 14 at 10:18 AM
	Zacks: Analysts Set $30.00 Target Price for Genmab A/S (NASDAQ:GMAB) www.americanbankingnews.com - August 13 at 10:56 AM
	Royal Bank of Canada Initiates Coverage on Genmab A/S (NASDAQ:GMAB) www.americanbankingnews.com - August 12 at 12:02 PM
	Genmab A/S (NASDAQ:GMAB) Earns Overweight Rating from Analysts at Morgan Stanley www.americanbankingnews.com - August 12 at 12:02 PM
	Guggenheim Begins Coverage on Genmab A/S (NASDAQ:GMAB) www.americanbankingnews.com - August 12 at 10:37 AM

This page was last updated on 8/24/2019 by MarketBeat.com Staff

Headlines